CATEGORIES

Industry News

LATEST

TRENDING

EDITORS CHOICE

FDA Approval of New Drug for Alzheimer’s Offers Hope

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

The Future of Post-Acute Care

Too often, patients needing Post Acute Care do not have the critical information they need to carefully assess their options and make informed choices

The Journey from Analog Patient to Virtual Health Consumer

Provider behavior must follow patient-consumer behavior. Health systems and physicians that are slow to adopt could find themselves quickly falling behind in the healthcare marketplace in the years to come.